Gastroenterology

Covidien has unveiled its new range add HALO 90 ULTRA for ablative treatment of large Barrett’s Oesophagus lesions. The device, which comes from the stable of recently acquired Barrx Medical, is double the length of its HALO 90 brother and as such can reduce ablation treatment time and in so doing shorten the procedure.

Another approach to reducing calorific intake is demonstrated with the newly CE marked Satisphere device, an endoscopically inserted series of balloons on a wire, which retain gut contents in the duodenum for longer, creating the feeling of satiation and therefore reducing appetite.

GI Dynamics Inc is no doubt delighted to see its product featuring at the Obesity and metabolic Disorders congress, especially as a presentation suggests its Endobarrier® device can be used a second time on the same patient without problems.

Capsule Endoscopy marches forward with Given Imaging announcing the expansion of its indications in Japan to cover visualisation and diagnosis of Crohn’s disease.

Torax’s LINX system of magnets acting to support the oesophageal sphincter gains FDA clearance.

Covidien’s November 2011 acquisition of BARRX Medical Inc is followed now by the launch of a new dimension catheter to make treatment of Barrett’s Esophagus easier.

Fiendishly clever scientists from San Diego have described a microrocket, which would exploit low pH conditions to elicit drive from a chemical reaction. Suggested applications on a postcard please.

Sphincter specialist Torax Medical Inc. has taken a significant step towards FDA approval for its Linx device, designed for treatment of Gastro-Oesophageal-Reflux Disease by gaining the unanimous support of FDA’s 9 member advisory panel.

GI Dynamics, Inc. is to transition its EndoBarrier® Gastrointestinal Liner from clinical research status to commercial availability in Netherlands.

California-based Magnetecs Corporation has reported that the company’s Robotic Catheter Guidance Control and Imaging™ (CGCI) System has received CE Marking certification.

Tel Aviv University researcher proposes MRI-controllable capsule endoscope to investigate digestive system

US non-surgical obesity solutions company GI Dynamics, Inc. today announced that it has designated two new Centres of Excellence in Germany, bringing to three the number of specialist units offering the Endobarrier treatment in the country.

BÂRRX Medical Inc., a leader in developing minimally invasive medical devices to remove precancerous tissue from the gastrointestinal tract, has announced today that it has signed a definitive agreement to be acquired by Covidien.

Ethicon Endo-Surgery, Inc. has announced U.S. FDA 510(k) clearance of its innovative ENSEAL® G2 Curved and Straight Tissue Sealers

Smooth Muscle Cells and Tengion’s Proprietary Biological Scaffolding Spurs Small Intestine Regeneration as Early as Eight Weeks After Implantation.

IntraPace, Inc. has announced that it has received CE Mark for the LGL102, a new gastric stimulation/food sensing lead designed to work with the innovative abiliti(R) system, an implantable weight loss management system.